Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,658 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Qualcomm sits at a critical crossroads in the semiconductor world, with strong fundamentals and steady cash flow. Thi...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
As markets shift, the question isn’t just 'do I buy index funds?'—it’s 'could picking individual stocks better positi...
What if you put $5,000 into Nvidia in 1999 and never sold? From IPO excitement to AI-dominated GPUs, the journey reve...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
As cannabis markets evolve, Green Thumb Industries stands out for its cash generation, branding, and disciplined grow...
In stock market today, june, BlackBerry delivered a powerful earnings beat that sparked a rally in its shares. This p...
When conviction runs hot but capital is capped, traditional 1:1 bets may feel limiting. The forget returns: double-le...
Three quantum hardware players—IonQ, D-Wave, and Rigetti—are confronting a tough market reality. This article breaks ...
Two tech giants sit in different lanes: Descartes System Group provides logistics backbone for global trade, while nC...
The question 'Is corp. stock seriously undervalued?' isn’t easy to answer for FMC. A mix of debt, patent risk, and a ...